Keywords: dosing, initiated, ph, iii, balaglitazone, trial, danish

Dosing initiated in Ph III balaglitazone trial

Article | 06 August 2007

Print This

Danish biopharmaceutical company Rheoscience AS and Indian drugmaker Dr Reddy's have begun dosing patients in a Phase III trial of ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in